Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 13;13(15):19475–19485. doi: 10.18632/aging.203359

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2021 Zhang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Immunohistochemistry analysis of FKBP10 and PLOD2 in ccRCC. Immunohistochemistry data of FKBP10 and PLOD2 in ccRCC samples and normal kidney tissues from the HPA database. (A) FKBP10 in normal kidney tissue. Antibody HPA057021, patient ID 1859. FKBP10 in glomeruli: staining not detected, weak intensity, quantity<25%, located in cytoplasmic/membranous; FKBP10 tubules: low staining, weak intensity, quantity 25%-75%, membranous. (B) PLOD 2 in normal kidney tissue. Antibody CAB025898, patient ID 1933. PLOD2 in glomeruli: low staining, moderate intensity, quantity<25%, located in cytoplasmic membranous; PLOD2 tubules: medium staining, moderate intensity, quantity>75%, membranous. (C) FKBP 10 in ccRCC tissue. Antibody HPA057021, patient ID 3039. FKBP10 in ccRCC tissue: high staining, strong intensity, quantity>75%, located in cytoplasmic/membranous. (D) PLOD2 in ccRCC tissue. Antibody CAB025898, patient ID 2564. PLOD2 in ccRCC tissue: high staining, strong intensity, quantity>75%, located in cytoplasmic/membranous.